Intrathecal administration
Showing 26 - 50 of >10,000
MSA Trial in Rochester (Autologous Mesenchymal Stem Cells)
Active, not recruiting
- MSA
- Autologous Mesenchymal Stem Cells
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 7, 2021
Tay-Sachs Disease, Sandhoff Disease Trial in Boston, Worcester (AXO-AAV-GM2 Starting Dose, AXO-AAV-GM2 Low Dose, AXO-AAV-GM2
Recruiting
- Tay-Sachs Disease
- Sandhoff Disease
- AXO-AAV-GM2 Starting Dose
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2021
Multiple Sclerosis Trial (Injection of autologous bone marrow derived mesenchymal stem cells)
Completed
- Multiple Sclerosis
- Injection of autologous bone marrow derived mesenchymal stem cells
- (no location specified)
Mar 24, 2021
Spinal Cord Injury, Chronic Trial in Badalona (XCEL-UMC-BETA, Placebo)
Completed
- Spinal Cord Injury, Chronic
- XCEL-UMC-BETA
- Placebo
-
Badalona, Barcelona, SpainHospital de Neurorehabilitació Institut Guttmann
Feb 13, 2020
Antishivering Effects Trial in Shenyang (bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid)
Withdrawn
- Antishivering Effects
- bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid
-
Shenyang, Liaoning, Chinathe First Hospital of China Medical University
Nov 18, 2019
Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)
Recruiting
- Leptomeningeal Metastasis
- Pemetrexed
- Radiotherapy
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 8, 2022
Glioblastoma Trial (Tislelizumab and Bevacizumab)
Not yet recruiting
- Glioblastoma
- Tislelizumab and Bevacizumab
- (no location specified)
Apr 12, 2023
Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])
Recruiting
- Leptomeningeal Disease
- Nivolumab [Opdivo]
-
Freiburg, Germany
- +6 more
Nov 2, 2022
Multiple System Atrophy, MSA - Multiple System Atrophy Trial in Tel Aviv (hOMSC300, Sham Procedure)
Recruiting
- Multiple System Atrophy
- MSA - Multiple System Atrophy
- hOMSC300
- Sham Procedure
-
Tel Aviv, IsraelTel-Aviv Sourasky Medical Center (Ichilov)
Jan 24, 2023
Advanced Cancer, Intractable Pain Trial in France (Implantable pump with continuous flow, Implantable pump with programmable
Completed
- Advanced Cancer
- Intractable Pain
- Implantable pump with continuous flow
- Implantable pump with programmable flow.
-
Angers, France
- +5 more
Mar 23, 2020
Fractures, Bone, Nausea and Vomiting, Postoperative, Pruritus Trial in Sorocaba (Dexamethasone, Ondansetron, Saline)
Completed
- Fractures, Bone
- +4 more
- Dexamethasone
- +2 more
-
Sorocaba, SP, BrazilSanta Lucinda Hospital
Mar 5, 2020
NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)
Not yet recruiting
- NSCLC Associated With Leptomeningeal Metastases
- Tislelizumab, pemetrexed
- (no location specified)
Nov 21, 2023
Amyotrophic Lateral Sclerosis Trial in Czestochowa (Mesenchymal stem cells isolated from Wharton's jelly)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Mesenchymal stem cells isolated from Wharton's jelly
-
Częstochowa, PolandJST sp. z o.o.
Apr 27, 2022
Pain Control Trial in Rochester (Hydromorphone 2.5 mcg/kg, Hydromorphone 2.75 mcg/kg, Hydromorphone 3 mcg/kg)
Not yet recruiting
- Pain Control
- Hydromorphone 2.5 mcg/kg
- +7 more
-
Rochester, MinnesotaMayo Clinic Rochester
Dec 13, 2022
NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)
Recruiting
- Non-small Cell Lung Cancer
- Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
-
Chongqing, Chinachongqing University Three Gorges Hospital
Apr 11, 2023
Regional Anesthesia Morbidity, Cesarean Section Complications, Local Anesthetic Complication Trial (standardized dose, adjusted
Not yet recruiting
- Regional Anesthesia Morbidity
- +2 more
- standardized dose
- adjusted dose
- (no location specified)
Jan 31, 2022
Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)
Not yet recruiting
- Spinal Cord Injuries
- Mesenchymal stem cell transplantation
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jan 10, 2023
Ketamine Causing Adverse Effects in Therapeutic Use Trial in Assiut (Ketamine 0.1 mg, Ketamine 0.2 mg, Ketamine 0.3 mg)
Recruiting
- Ketamine Causing Adverse Effects in Therapeutic Use
- Ketamine 0.1 mg
- +2 more
-
Assiut, EgyptAssiut University hospital
Apr 17, 2022
Intrathecal Local Anesthetics on Left Ventricular Global
Not yet recruiting
- Left Ventricular Dysfunction
- +2 more
- Intrathecal local anesthesia
- (no location specified)
Dec 6, 2022
Acute Pain, Post Operative Pain, Anorectal Disorder Trial in Shanghai (Intrathecal Hydromorphone Mono Injection, Intrathecal
Recruiting
- Acute Pain
- +3 more
- Intrathecal Hydromorphone Mono Injection
- Intrathecal Placebo Mono Injection
-
Shanghai, Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
Oct 20, 2022
Pain, Postoperative, Obesity, Respiratory Insufficiency Trial (Intrathecal Morphine, Intravenous hydromorphone)
Withdrawn
- Pain, Postoperative
- +2 more
- Intrathecal Morphine
- Intravenous hydromorphone
- (no location specified)
May 5, 2022
Healthy Volunteer Study Trial in Winston-Salem (Oxytocin 15 mcg, Oxytocin 150 mcg, Placebo)
Terminated
- Healthy Volunteer Study
- Oxytocin 15 mcg
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Dec 4, 2022
Pain, Postoperative Trial (Brivoligide Injection 660 mg/6 mL, Placebo 6 mL)
Withdrawn
- Pain, Postoperative
- Brivoligide Injection 660 mg/6 mL
- Placebo 6 mL
- (no location specified)
Jul 9, 2020